Σφακιανάκης Αλέξανδρος
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5 Άγιος Νικόλαος
Κρήτη 72100
00302841026182
00306932607174
alsfakia@gmail.com

Αρχειοθήκη ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader

Η λίστα ιστολογίων μου

Δευτέρα 16 Νοεμβρίου 2020

Patisiran in hereditary transthyretin-mediated amyloidosis

alkiviadis.1961 shared this article with you from Inoreader
The clinical course of hereditary transthyretin-mediated amyloidosis has substantially changed in the past 10 years.1 Several clinical studies have widened the therapeutic landscape for the condition, including transthyretin (TTR) stabilisers and TTR gene silencers. The use of liver transplantation, which, until a few years ago, represented the only therapeutic choice, is now declining.1 Furthermore, new monoclonal antibodies targeting TTR deposits could be tested in future clinical trials.1
View on the web

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου